FIXX
Homology Medicines, Inc. Common Stock
US Stock$1.7
Open: $1.51 High: $1.6 Low: $1.45 Close: $1.46
Range: 2022-05-18 - 2022-05-19
Volume:98,450Market: Extended-hours
Powered by Finage Stock APIDelayed data
FIXX
Homology Medicines, Inc. Common Stock ONE PATRIOTS PARK https://www.homologymedicines.com
Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.- CEO:
- Employees: 104
- Sector:
- Industry:
FIXX News
Latest news about the FIXX
- Britain's Oxford Biomedica enters into deal to expand viral vector offerings by Reuters at 1/28/22, 9:27 AMView More →
- BRIEF-Homology Medicines Announces Peer-Reviewed Publication Of HMI-102 Investigational Gene Therapy by Reuters at 3/16/20, 1:28 PMView More →